Showing 1 - 5 of 5
Using annual cross-sectional data on over 100,000 adolescents aged 12-17, we studied academic and behavioral outcomes among those who were and were not likely affected by FDA warnings regarding the safety of antidepressants. Just before the FDA warnings, adolescents with probable depression had...
Persistent link: https://www.econbiz.de/10013092388
Persistent link: https://www.econbiz.de/10009314057
Persistent link: https://www.econbiz.de/10010409893
Persistent link: https://www.econbiz.de/10011580003
Using annual cross-sectional data on over 100,000 adolescents aged 12-17, we studied academic and behavioral outcomes among those who were and were not likely affected by FDA warnings regarding the safety of antidepressants. Just before the FDA warnings, adolescents with probable depression had...
Persistent link: https://www.econbiz.de/10012461232